Vanguard Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $64.9M | Buy |
32,777,257
+5,122,052
| +19% | +$11.6M | ﹤0.01% | 2032 |
|
|
2025
Q3 | $68M | Buy |
27,655,205
+5,837,898
| +27% | +$15M | ﹤0.01% | 2015 |
|
|
2025
Q2 | $57.6M | Buy |
21,817,307
+1,472,753
| +7% | +$3.96M | ﹤0.01% | 2063 |
|
|
2025
Q1 | $61.2M | Buy |
20,344,554
+3,016,325
| +17% | +$9.14M | ﹤0.01% | 2010 |
|
|
2024
Q4 | $44.4M | Buy |
17,328,229
+425,713
| +3% | +$1.77M | ﹤0.01% | 2214 |
|
|
2024
Q3 | $62.9M | Buy |
16,902,516
+3,070,720
| +22% | +$14.2M | ﹤0.01% | 2078 |
|
|
2024
Q2 | $87.4M | Buy |
13,831,796
+292,206
| +2% | +$1.93M | ﹤0.01% | 1898 |
|
|
2024
Q1 | $72.7M | Buy |
13,539,590
+211,065
| +2% | +$956K | ﹤0.01% | 2016 |
|
|
2023
Q4 | $66.9M | Sell |
13,328,525
-1,347,162
| -9% | -$4.23M | ﹤0.01% | 2068 |
|
|
2023
Q3 | $24.8M | Buy |
14,675,687
+4,342,386
| +42% | +$8.72M | ﹤0.01% | 2465 |
|
|
2023
Q2 | $28.7M | Buy |
10,333,301
+2,047,343
| +25% | +$5.79M | ﹤0.01% | 2431 |
|
|
2023
Q1 | $15.1M | Buy |
8,285,958
+30,712
| +0.4% | +$95.5K | ﹤0.01% | 2729 |
|
|
2022
Q4 | $41.9M | Buy |
8,255,246
+175,705
| +2% | +$965K | ﹤0.01% | 2267 |
|
|
2022
Q3 | $40.2M | Buy |
8,079,541
+557,164
| +7% | +$2.54M | ﹤0.01% | 2290 |
|
|
2022
Q2 | $28M | Buy |
7,522,377
+366,231
| +5% | +$1.47M | ﹤0.01% | 2478 |
|
|
2022
Q1 | $40.1M | Buy |
7,156,146
+17,609
| +0.2% | +$108K | ﹤0.01% | 2410 |
|
|
2021
Q4 | $43.4M | Buy |
7,138,537
+107,279
| +2% | +$806K | ﹤0.01% | 2432 |
|
|
2021
Q3 | $68.5M | Buy |
7,031,258
+1,471,235
| +26% | +$16.2M | ﹤0.01% | 2191 |
|
|
2021
Q2 | $79.4M | Buy |
5,560,023
+3,000,632
| +117% | +$49.6M | ﹤0.01% | 2116 |
|
|
2021
Q1 | $60.8M | Buy |
2,559,391
+531,509
| +26% | +$13.8M | ﹤0.01% | 2209 |
|
|
2020
Q4 | $27M | Buy |
2,027,882
+161,614
| +9% | +$1.55M | ﹤0.01% | 2494 |
|
|
2020
Q3 | $12.9M | Buy |
1,866,268
+133,225
| +8% | +$1.33M | ﹤0.01% | 2662 |
|
|
2020
Q2 | $21.3M | Buy |
1,733,043
+341,483
| +25% | +$1.93M | ﹤0.01% | 2394 |
|
|
2020
Q1 | $4.01M | Buy |
1,391,560
+318,040
| +30% | +$1.59M | ﹤0.01% | 3061 |
|
|
2019
Q4 | $4.07M | Buy |
1,073,520
+174
| +0% | +$296 | ﹤0.01% | 3234 |
|
|
2019
Q3 | $1.31M | Buy |
1,073,346
+100,225
| +10% | +$124K | ﹤0.01% | 3570 |
|
|
2019
Q2 | $993K | Sell |
973,121
-386,555
| -28% | -$446K | ﹤0.01% | 3681 |
|
|
2019
Q1 | $2.15M | Buy |
1,359,676
+125,280
| +10% | +$157K | ﹤0.01% | 3425 |
|
|
2018
Q4 | $1.43M | Buy |
1,234,396
+3,691
| +0.3% | +$8.45K | ﹤0.01% | 3463 |
|
|
2018
Q3 | $4.55M | Buy |
1,230,705
+2,508
| +0.2% | +$7.93K | ﹤0.01% | 3271 |
|
|
2018
Q2 | $3.76M | Sell |
1,228,197
-432,812
| -26% | -$1.6M | ﹤0.01% | 3307 |
|
|
2018
Q1 | $6.46M | Sell |
1,661,009
-178,378
| -10% | -$782K | ﹤0.01% | 3041 |
|
|
2017
Q4 | $8.26M | Buy |
1,839,387
+241,784
| +15% | +$1.14M | ﹤0.01% | 2904 |
|
|
2017
Q3 | $8.75M | Buy |
1,597,603
+109,914
| +7% | +$677K | ﹤0.01% | 2876 |
|
|
2017
Q2 | $11.3M | Sell |
1,487,689
-595,017
| -29% | -$2.57M | ﹤0.01% | 2717 |
|
|
2017
Q1 | $7.39M | Buy |
2,082,706
+160,510
| +8% | +$793K | ﹤0.01% | 2891 |
|
|
2016
Q4 | $11M | Buy |
1,922,196
+88,033
| +5% | +$587K | ﹤0.01% | 2700 |
|
|
2016
Q3 | $14.3M | Buy |
1,834,163
+250,878
| +16% | +$1.87M | ﹤0.01% | 2518 |
|
|
2016
Q2 | $9.85M | Buy |
1,583,285
+193,338
| +14% | +$1.5M | ﹤0.01% | 2655 |
|
|
2016
Q1 | $11.4M | Buy |
1,389,947
+654,682
| +89% | +$6.17M | ﹤0.01% | 2543 |
|
|
2015
Q4 | $12.7M | Buy |
735,265
+689,898
| +1,521% | +$10.2M | ﹤0.01% | 2503 |
|
|
2015
Q3 | $519K | Buy |
+45,367
| New | +$990K | ﹤0.01% | 3842 |
|
Other funds holding IBRX
WP
AC